LuciDeucra

LuciDeucra uses and dosage

LuciDeucra (Deucravacitinib), generic SOTYKTU is a prescription medicine used to treat certain type of skin condition (moderate-to-severe plaque psoriasis) in patients who need systemic therapy or phototherapy. Deucravacitinib should not be used with other potent immunosuppressants. Deucravacitinibis a drug that blocks the activity of tyrosine kinase 2 (TYK2), an enzyme that is involved in inflammation and immune responses. Deucravacitinib binds to a part of TYK2 that regulates its function, and prevents it from being activated by certain receptors on the cell surface. This reduces the signaling of proteins called STATs, which are important for the development of psoriasis. TYK2 works with other enzymes called JAKs to form pairs that transmit signals from different cytokines, which are molecules that regulate inflammation and immunity. Deucravacitinib can inhibit the pairs of TYK2 and JA

LuciDeucra side effects

The most common adverse reactions of Deucravacitinib are: common cold, sore throat, and sinus infection (upper respiratory infections), cold sores (herpes simplex), sores on inner lips, gums, tongue, or roof of the mouth (canker sores), inflamed hair pores (folliculitis), acne. It may cause serious allergic reactions including feeling faint or swelling in the face, eyelids, lips, mouth, tongue, or throat, trouble breathing or throat tightness or chest tightness or skin rash, hives etc.

Originator brand

SOTYKTU by BRISTOL

Made by

Lucius Pharma

This information is provided for reference only and is not medical advice. Always consult a qualified healthcare professional.